In one paragraphArticle in Journal of personalized medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
22 authors.
Ángel Pérez-SempereDepartment of Neurology, Hospital Universitario General de Alicante, Universidad Miguel Hernández, 03010 Alicante, Spain.
Jacobo Caruncho PérezAVEMPO (Asociación Viguesa de Esclerosis Múltiple de Pontevedra), 36208 Vigo, Spain.
Aida OrvizDepartment of Neurology, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain.
Jesús Martín-MartínezDepartment of Neurology, Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain.ORCID 0000-0003-0326-3941 Raquel Piñar-MoralesDepartment of Neurology, Hospital Universitario Clínico San Cecilio, 18007 Granada, Spain.ORCID 0000-0003-3490-4932 Elena Álvarez-RodríguezDepartment of Neurology, Hospital Universitario Álvaro Cunqueiro, 36312 Vigo, Spain.
Eva M Pacheco-CorteganaDepartment of Neurology, Hospital Universitario Juan Ramón Jiménez, 21005 Huelva, Spain.
Laura BorregaDepartment of Neurology, Hospital Universitario Fundación Alcorcón, 28922 Madrid, Spain.ORCID 0000-0002-1425-1789 José Luis Sánchez-MenoyoDepartment of Neurology, Galdakao-Usansolo University Hospital, Osakidetza (Basque Health Service), 48960 Usansolo, Spain.ORCID 0000-0003-2634-8294 Montserrat Gómez-GutiérrezDepartment of Neurology, Hospital San Pedro de Alcántara, 10003 Cáceres, Spain.
Carmen CallesDepartment of Neurology, Hospital Universitari Son Espases, 07120 Palma, Spain.
Miguel Ángel HernándezDepartment of Neurology, Hospital Nuestra Señora de la Candelaria, 38010 Tenerife, Spain.
Pablo López-MuñozDepartment of Neurology, Hospital Llíria Arnau, 46160 Llíria, Spain.
Enric MonrealDepartment of Neurology, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
Inés González-SuárezDepartment of Neurology, Hospital Universitario Álvaro Cunqueiro, 36312 Vigo, Spain.ORCID 0000-0002-9897-0771 Funding
Roche Farma Not applicable
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
biomarkermultiple sclerosispatient preferencepersonalized medicineserum neurofilament light chainshared decision-making
Identifiers
PMID42042552
PMCPMC13117150
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390